Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging

In breast cancer, the prognosis of human epidermal growth factor receptor 2 (HER2)-positive patients (20–25%) has been dramatically improved by the clinical application of the anti-HER2 antibody drugs trastuzumab and pertuzumab. However, the clinical outcomes of HER2-negative cases with a poor progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonda, Kohsuke, Miyashita, Minoru, Higuchi, Hideo, Tada, Hiroshi, Watanabe, Tomonobu M., Watanabe, Mika, Ishida, Takanori, Ohuchi, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585722/
https://www.ncbi.nlm.nih.gov/pubmed/26392299
http://dx.doi.org/10.1038/srep14322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585722/
https://www.ncbi.nlm.nih.gov/pubmed/26392299
http://dx.doi.org/10.1038/srep14322

Ejemplares similares